SMC HEALTHCARE

Specialized Medical Company

4019StocksTadawulHealthcare

Financials

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Annual (SAR)

1-5

	2025Dec 31, 2025	2024Dec 31, 2024	2023Dec 31, 2023	2022Dec 31, 2022	2021Dec 31, 2021
Operating Summary
Revenue	1.54B	1.44B	1.37B	1.21B	1.05B
Cost of Revenue	1.16B	1.08B	1.02B	0.93B	0.82B
Gross Profit	381.59M	361.06M	348.96M	278.66M	228.24M
SG&A	146.60M	130.59M	134.38M	150.91M	159.04M
Operating Expenses	146.60M	130.59M	134.38M	150.91M	159.04M
Operating Income	234.99M	230.47M	214.58M	127.75M	69.20M
Interest Expense	-42.47M	-45.17M	-48.46M	-29.82M	-18.89M
Other Income/Expense	19.36M	8.35M	8.52M	9.13M	8.98M
Pretax Income	272.50M	193.66M	174.70M	107.12M	59.29M
Income Tax	6.27M	8.44M	6.00M	4.15M	3.32M
Net Income	266.23M	185.22M	168.70M	102.96M	55.97M
EBITDA	297.44M	288.94M	273.08M	202.59M	141.55M
EBIT	234.99M	230.47M	214.58M	127.75M	69.20M
EPS (Basic)	1.06	0.74	1.98	1.21	0.66
EPS (Diluted)	1.06	0.74	1.98	1.21	0.66
Margins & Efficiency
Gross Margin %	+24.8%	+25.1%	+25.5%	+23.1%	+21.7%
EBITDA Margin %	+19.3%	+20.1%	+20.0%	+16.8%	+13.4%
Net Margin %	+17.3%	+12.9%	+12.3%	+8.5%	+5.3%
Revenue & Income
Revenue	1.54B	1.44B	1.37B	1.21B	1.05B
Revenue Growth (YoY)	+7.0%	+5.1%	+13.2%	+14.8%	+21.4%
Gain (Loss) on Sale of Assets	60.63M	—	0.05M	0.06M	—
Expenses & Provisions
Advertising Expenses	15.99M	8.95M	—	—	—
Cost of Revenue	1.16B	1.08B	1.02B	0.93B	0.82B
Selling, General & Admin	146.60M	130.59M	134.38M	150.91M	159.04M
Operating Expenses	146.60M	130.59M	134.38M	150.91M	159.04M
Interest Expense	-42.47M	-45.17M	-48.46M	-29.82M	-18.89M
Other Non Operating Income (Expenses)	19.36M	8.35M	8.52M	9.13M	8.98M
D&A For EBITDA	62.46M	58.47M	58.49M	74.85M	72.35M
Profitability & Returns
Gross Profit	381.59M	361.06M	348.96M	278.66M	228.24M
Gross Margin	+24.8%	+25.1%	+25.5%	+23.1%	+21.7%
EBIT	234.99M	230.47M	214.58M	127.75M	69.20M
EBIT Margin	+15.3%	+16.0%	+15.7%	+10.6%	+6.6%
EBITDA	297.44M	288.94M	273.08M	202.59M	141.55M
EBITDA Margin	+19.3%	+20.1%	+20.0%	+16.8%	+13.4%
EBT Excluding Unusual Items	211.87M	193.66M	174.65M	107.05M	59.29M
Pretax Income	272.50M	193.66M	174.70M	107.12M	59.29M
Operating Income	234.99M	230.47M	214.58M	127.75M	69.20M
Operating Margin	+15.3%	+16.0%	+15.7%	+10.6%	+6.6%
Profit Margin	+17.3%	+12.9%	+12.3%	+8.5%	+5.3%
Net Income	266.23M	185.22M	168.70M	102.96M	55.97M
Net Income to Common	266.23M	185.22M	168.70M	102.96M	55.97M
Net Income Growth	+43.7%	+9.8%	+63.8%	+84.0%	+21.6%
Income Tax Expense	6.27M	8.44M	6.00M	4.15M	3.32M
Effective Tax Rate	+2.3%	+4.4%	+3.4%	+3.9%	+5.6%
Per Share & Capital
EPS (Basic)	1.06	0.74	1.98	1.21	0.66
EPS (Diluted)	1.06	0.74	1.98	1.21	0.66
EPS Growth	+43.7%	-62.7%	+63.8%	+84.0%	+21.6%
Shares Change (YoY)	—	1.94	—	—	—
Shares Outstanding (Basic)	250.00M	250.00M	85.00M	85.00M	85.00M
Shares Outstanding (Diluted)	250.00M	250.00M	85.00M	85.00M	85.00M
Free Cash Flow	228.28M	289.52M	160.53M	116.60M	-159.38M
Free Cash Flow Margin	+14.8%	+20.1%	+11.7%	+9.6%	-15.1%
Free Cash Flow Per Share	0.91	1.16	1.89	1.37	-1.88
Payout Ratio	—	+108.0%	+35.6%	+48.6%	+62.5%

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Annual (SAR)

1-5

	2025Dec 31, 2025	2024Dec 31, 2024	2023Dec 31, 2023	2022Dec 31, 2022	2021Dec 31, 2021
Operating Summary
Revenue	1.54B	1.44B	1.37B	1.21B	1.05B
Cost of Revenue	1.16B	1.08B	1.02B	0.93B	0.82B
Gross Profit	381.59M	361.06M	348.96M	278.66M	228.24M
SG&A	146.60M	130.59M	134.38M	150.91M	159.04M
Operating Expenses	146.60M	130.59M	134.38M	150.91M	159.04M
Operating Income	234.99M	230.47M	214.58M	127.75M	69.20M
Interest Expense	-42.47M	-45.17M	-48.46M	-29.82M	-18.89M
Other Income/Expense	19.36M	8.35M	8.52M	9.13M	8.98M
Pretax Income	272.50M	193.66M	174.70M	107.12M	59.29M
Income Tax	6.27M	8.44M	6.00M	4.15M	3.32M
Net Income	266.23M	185.22M	168.70M	102.96M	55.97M
EBITDA	297.44M	288.94M	273.08M	202.59M	141.55M
EBIT	234.99M	230.47M	214.58M	127.75M	69.20M
EPS (Basic)	1.06	0.74	1.98	1.21	0.66
EPS (Diluted)	1.06	0.74	1.98	1.21	0.66
Margins & Efficiency
Gross Margin %	+24.8%	+25.1%	+25.5%	+23.1%	+21.7%
EBITDA Margin %	+19.3%	+20.1%	+20.0%	+16.8%	+13.4%
Net Margin %	+17.3%	+12.9%	+12.3%	+8.5%	+5.3%
Revenue & Income
Revenue	1.54B	1.44B	1.37B	1.21B	1.05B
Revenue Growth (YoY)	+7.0%	+5.1%	+13.2%	+14.8%	+21.4%
Gain (Loss) on Sale of Assets	60.63M	—	0.05M	0.06M	—
Expenses & Provisions
Advertising Expenses	15.99M	8.95M	—	—	—
Cost of Revenue	1.16B	1.08B	1.02B	0.93B	0.82B
Selling, General & Admin	146.60M	130.59M	134.38M	150.91M	159.04M
Operating Expenses	146.60M	130.59M	134.38M	150.91M	159.04M
Interest Expense	-42.47M	-45.17M	-48.46M	-29.82M	-18.89M
Other Non Operating Income (Expenses)	19.36M	8.35M	8.52M	9.13M	8.98M
D&A For EBITDA	62.46M	58.47M	58.49M	74.85M	72.35M
Profitability & Returns
Gross Profit	381.59M	361.06M	348.96M	278.66M	228.24M
Gross Margin	+24.8%	+25.1%	+25.5%	+23.1%	+21.7%
EBIT	234.99M	230.47M	214.58M	127.75M	69.20M
EBIT Margin	+15.3%	+16.0%	+15.7%	+10.6%	+6.6%
EBITDA	297.44M	288.94M	273.08M	202.59M	141.55M
EBITDA Margin	+19.3%	+20.1%	+20.0%	+16.8%	+13.4%
EBT Excluding Unusual Items	211.87M	193.66M	174.65M	107.05M	59.29M
Pretax Income	272.50M	193.66M	174.70M	107.12M	59.29M
Operating Income	234.99M	230.47M	214.58M	127.75M	69.20M
Operating Margin	+15.3%	+16.0%	+15.7%	+10.6%	+6.6%
Profit Margin	+17.3%	+12.9%	+12.3%	+8.5%	+5.3%
Net Income	266.23M	185.22M	168.70M	102.96M	55.97M
Net Income to Common	266.23M	185.22M	168.70M	102.96M	55.97M
Net Income Growth	+43.7%	+9.8%	+63.8%	+84.0%	+21.6%
Income Tax Expense	6.27M	8.44M	6.00M	4.15M	3.32M
Effective Tax Rate	+2.3%	+4.4%	+3.4%	+3.9%	+5.6%
Per Share & Capital
EPS (Basic)	1.06	0.74	1.98	1.21	0.66
EPS (Diluted)	1.06	0.74	1.98	1.21	0.66
EPS Growth	+43.7%	-62.7%	+63.8%	+84.0%	+21.6%
Shares Change (YoY)	—	1.94	—	—	—
Shares Outstanding (Basic)	250.00M	250.00M	85.00M	85.00M	85.00M
Shares Outstanding (Diluted)	250.00M	250.00M	85.00M	85.00M	85.00M
Free Cash Flow	228.28M	289.52M	160.53M	116.60M	-159.38M
Free Cash Flow Margin	+14.8%	+20.1%	+11.7%	+9.6%	-15.1%
Free Cash Flow Per Share	0.91	1.16	1.89	1.37	-1.88
Payout Ratio	—	+108.0%	+35.6%	+48.6%	+62.5%